Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.25 (
chymopapain
)
430
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phage lytic enzymes (enzybiotics) have gained attention as prospective tools to eradicate Gram-positive pathogens resistant to antibiotics. Attempts to purify the
P16
endolysin of Staphylococcus aureus phage P68 were unsuccessful owing to the poor solubility of the protein. To overcome this limitation, we constructed a chimeric endolysin (
P16
-17) comprised of the inferred N-terminal d-alanyl-
glycyl endopeptidase
domain and the C-terminal cell wall targeting domain of the S. aureus phage
P16
endolysin and the P17 minor coat protein, respectively. The domain swapping approach and the applied purification procedure resulted in soluble
P16
-17 protein, which exhibited antimicrobial activity towards S. aureus. In addition,
P16
-17 augmented the antimicrobial efficacy of the antibiotic gentamicin. This synergistic effect could be useful to reduce the effective dose of aminoglycoside antibiotics.
...
PMID:Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus. 1894 Feb 9